Articles

Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms

Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan;College of Medicine, Chang Gung University, Tao-Yuan, Taiwan
Division of Hematology and Oncology, Department of Medicine, Lotung Poh-Ai Hospital, Yilan, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan;College of Medicine, Chang Gung University, Tao-Yuan, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan
Department of Life Science and Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan;College of Medicine, Chang Gung University, Tao-Yuan, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan;College of Medicine, Chang Gung University, Tao-Yuan, Taiwan
Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan
School of Medicine, National Yang-Ming University, Taipei, Taiwan;Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taiwan
Vol. 102 No. 3 (2017): March, 2017 https://doi.org/10.3324/haematol.2016.154385